ACE2 and COVID-19: The components of AYUSH-64 exhibit potential in mitigating initial COVID-19 symptoms, suppressing the cytokine storm, inhibiting Angiotensin-Converting Enzyme II (ACE2), and reducing Reactive Oxygen Species (ROS), thus preventing the progression of COVID-19.